CIK: 0001618205 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 9, 2016
Total Value ($000): $137,756 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CELGENE CORP | 779,051 | $76,838 | 55.8% | $111.66 | — | COM | 151020104 |
| — | ACCELERATE DIAGNOSTICS INC | 2,175,795 | $31,310 | 22.7% | $19.28 | — | COM | 00430H102 |
| EQT | EQT CORP | 42,300 | $3,275 | 2.4% | $43.27 | -17.3% | COM | 26884L109 |
| — | VERMILLION INC | 2,717,514 | $3,016 | 2.2% | $1.94 | — | COM | 92407M206 |
| — | HANSEN MEDICAL INC | 528,142 | $2,097 | 1.5% | $0.72 | — | COM | 411307101 |
| MASI | MASIMO CORP | 36,600 | $1,922 | 1.4% | $24.68 | +90.8% | COM | 574795100 |
| — | METABOLIX INC RESTRICTED | 2,263,166 | $1,691 | 1.2% | $0.40 | — | COM | 591018809 |
| — | BIOLASE INC | 1,285,903 | $1,505 | 1.1% | $2.49 | — | COM | 090911108 |
| — | CONTRAFECT CORP | 475,082 | $1,373 | 1.0% | $4.73 | — | COM | 212326102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 25,200 | $1,145 | 0.8% | $48.98 | -6.0% | COM | 64125C109 |
| — | MEDIVATION INC | 18,760 | $1,131 | 0.8% | $80.31 | — | COM | 58501N101 |
| — | ENCANA CORP | 132,300 | $1,031 | 0.7% | $10.76 | — | COM | 292505104 |
| — | ONCOMED PHARMACEUTICALS INC | 70,689 | $870 | 0.6% | $21.19 | — | COM | 68234X102 |
| MRK | MERCK & CO INC | 15,000 | $864 | 0.6% | $39.35 | +0.3% | COM | 58933Y105 |
| — | TESARO INC | 8,450 | $710 | 0.5% | $57.99 | — | COM | 881569107 |
| — | QUIDEL CORP | 38,975 | $696 | 0.5% | $28.92 | — | COM | 74838J101 |
| — | NXSTAGE MEDICAL INC | 28,200 | $611 | 0.4% | $19.24 | — | COM | 67072V103 |
| CTRA | CABOT OIL & GAS CORP | 21,000 | $541 | 0.4% | $22.79 | -23.4% | COM | 127097103 |
| — | WRIGHT MEDICAL GROUP NV | 30,000 | $521 | 0.4% | $24.17 | — | COM | 98235T107 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 56,303 | $507 | 0.4% | $11.59 | — | COM | G6855A103 |
| ARAY | ACCURAY INC | 95,300 | $495 | 0.4% | $7.05 | -22.5% | COM | 004397105 |
| — | PIONEER NATURAL RESOURCES CO (PXD) | 3,000 | $456 | 0.3% | $149.00 | — | COM | 723787107 |
| — | QUOTIENT LTD | 58,200 | $451 | 0.3% | $14.57 | — | COM | G73268107 |
| CORT | CORCEPT THERAPEUTICS INC | 80,000 | $437 | 0.3% | $4.51 | +15.3% | COM | 218352102 |
| — | SIENTRA INC | 63,300 | $417 | 0.3% | $10.15 | — | COM | 82621J105 |
| — | CELGENE CORP | 238,214 | $348 | 0.3% | $2.99 | — | RIGHT 12/31/2030 | 151020112 |
| — | RELYPSA INC | 18,000 | $333 | 0.2% | $18.50 | — | COM | 759531106 |
| — | ADVAXIS INC | 35,600 | $288 | 0.2% | $20.34 | — | COM | 007624208 |
| BIIB | BIOGEN INC | 1,000 | $242 | 0.2% | $323.51 | -18.5% | COM | 09062X103 |
| — | MERRIMACK PHARMACEUTICALS INC | 44,000 | $237 | 0.2% | $10.37 | — | COM | 590328100 |
| XNCR | XENCOR INC | 12,300 | $234 | 0.2% | $15.78 | -13.1% | COM | 98401F105 |
| — | RAPTOR PHARMACEUTICAL CORP | 40,000 | $215 | 0.2% | $11.61 | — | COM | 75382F106 |
| — | TRANSITION THERAPEUTICS INC | 145,746 | $214 | 0.2% | $6.84 | — | COM | 893716209 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 27,000 | $190 | 0.1% | $9.83 | -7.1% | COM | 69404D108 |
| — | INTERCEPT PHARMACEUTICALS INC | 1,300 | $185 | 0.1% | $128.46 | — | COM | 45845P108 |
| CERS | CERUS CORP | 26,500 | $165 | 0.1% | $5.12 | +16.2% | COM | 157085101 |
| — | GENOCEA BIOSCIENCES INC | 39,000 | $160 | 0.1% | $7.74 | — | COM | 372427104 |
| KURA | KURA ONCOLOGY INC | 59,114 | $160 | 0.1% | $10.42 | -70.2% | COM | 50127T109 |
| — | PARATEK PHARMACEUTICALS INC | 11,150 | $155 | 0.1% | $13.90 | — | COM | 699374302 |
| — | SERES THERAPEUTICS INC | 5,000 | $145 | 0.1% | $29.00 | — | COM | 81750R102 |
| — | ROKA BIOSCIENCE INC | 252,307 | $144 | 0.1% | $2.62 | — | COM | 775431109 |
| — | ALDER BIOPHARMACEUTICALS INC | 5,150 | $129 | 0.1% | $25.05 | — | COM | 014339105 |
| CHRS | COHERUS BIOSCIENCES INC | 7,500 | $127 | 0.1% | $25.85 | -27.4% | COM | 19249H103 |
| — | WORKHORSE GROUP INC | 15,000 | $103 | 0.1% | $6.87 | — | COM | 98138J206 |
| STTO | SITO MOBILE LTD | 20,000 | $72 | 0.1% | $3.02 | 0.0% | COM | 82988R203 |